Results 101 to 110 of about 5,254 (231)

Cyclosporin A Enhances IL-12 Production by CpG Motifs in Bacterial DNA and Synthetic Oligodeoxynucleotides [PDF]

, 1998
Thomas W. Redford, Ae‐Kyung Yi, Courtney T. Ward, Arthur Μ. Krieg   +3 more
openalex   +1 more source

CpG-Based Nanovaccines for Cancer Immunotherapy

International Journal of Nanomedicine, 2021
Wenqiang Chen,1 Mingxia Jiang,1 Wenjing Yu,1 Zhiwei Xu,1 Xinyue Liu,1 Qingmiao Jia,1 Xiuwen Guan,1– 3 Weifen Zhang1– 3 1College of Pharmacy, Weifang Medical University, Weifang, 261053, People’s Republic of China; 2Collaborative Innovation Center for ...
Chen W, Jiang M, Yu W, Xu Z, Liu X, Jia Q, Guan X, Zhang W   +7 more
doaj  

Free Feeding of CpG-Oligodeoxynucleotide Particles Prophylactically Attenuates Allergic Airway Inflammation and Hyperresponsiveness in Mice. [PDF]

Front Immunol, 2021
Okajima T, Shigemori S, Namai F, Ogita T, Sato T, Shimosato T.   +5 more
europepmc   +1 more source

Increased Resistance Against Acute Polymicrobial Sepsis in Mice Challenged with Immunostimulatory CpG Oligodeoxynucleotides Is Related to an Enhanced Innate Effector Cell Response [PDF]

, 2000
Heike Weighardt, Carolin Feterowski, Martin Veit, Martina Rump, Hermann Wagner, Bernhard Holzmann   +5 more
openalex   +1 more source

Routes of delivery for CpG and anti-CD137 for the treatment of orthotopic kidney tumors in mice.

PLoS ONE, 2014
We have found previously that the tumor cell lines, Renca (a renal cancer) and MC38 (a colon tumor) which had been injected subcutaneously in mice, could be successfully treated with a combination therapy of an oligodeoxynucleotide (CpG1826) (injected ...
Jennifer A Westwood, Titaina C U Potdevin Hunnam, Hollie J Pegram, Rodney J Hicks, Phillip K Darcy, Michael H Kershaw   +5 more
doaj   +1 more source

Sharpening up tumor microenvironment to enhance the efficacy of immune checkpoint blockade on head and neck cancer using a CpG-oligodeoxynucleotide. [PDF]

Cancer Immunol Immunother, 2022
Tseng JC, Yang JX, Liu YL, Su YW, Lee AY, Chen YW, Liu KJ, Luo Y, Hong YR, Chuang TH.   +9 more
europepmc   +1 more source

CpG‐oligodeoxynucleotides enhance T‐cell receptor‐triggered interferon‐γ production and up‐regulation of CD69 via induction of antigen‐presenting cell‐derived interferon type I and interleukin‐12 [PDF]

, 2000
Katharina Kranzer, Michael G. Bauer, Grayson B. Lipford, Klaus Heeg, Hermann Wagner, Roland Lang   +5 more
openalex   +1 more source

CpG Oligodeoxynucleotide Developed to Activate Primate Immune Responses Promotes Antitumoral Effects in Combination with a Neoantigen-Based mRNA Cancer Vaccine. [PDF]

Drug Des Devel Ther, 2021
Li Q, Ren J, Liu W, Jiang G, Hu R.
europepmc   +1 more source

CpG Oligodeoxynucleotides Act as Adjuvants for Pneumococcal Polysaccharide-Protein Conjugate Vaccines and Enhance Antipolysaccharide Immunoglobulin G2a (IgG2a) and IgG3 Antibodies [PDF]

, 2000
Rose S. Chu, Tera L. McCool, Neil S. Greenspan, John R. Schreiber, Clifford V. Harding   +4 more
openalex   +1 more source

Induction of liver-specific intrahepatic myeloid cells aggregation expands CD8 T cell and inhibits growth of murine hepatoma

OncoImmunology, 2018
Toll-Like Receptor 9 (TLR9) stimulation selectively triggers the formation of a cell cluster termed intrahepatic myeloid aggregation for T cell expansion” (iMATE) in a mouse chronic viral hepatitis model.
Yung-Chang Lin, Chen-Yu Hsu, Sheng-Kai Huang, Yun-Han Fan, Chien-Hao Huang, Chan-Keng Yang, Wan-Ting Su, Po-Chia Chang, Avijit Dutta, Yu-Jen Liu, Ching-Tai Huang, Tse-Ching Chen, Chun-Yen Lin   +12 more
doaj   +1 more source